Compound azimtamide entieric-coated tablets combined with mosapride for slow transmissive constipation: 295 cases

Objective To investigate and study the curative effect of compound azimtamide entieric-coated tablets combined with mosapride for slow transmissive constipation. Methods A total of 295 patients were randomly divided into 3 groups: 113 patients in treatment group were treated with compound azimtamide entieric-coated tablets combined with mosapride, 98 in control group A were treated with compound azimtamide entieric-coated tablets, and 84 in conrol group B were treated with mosapride. The 3 groups were treated for 3 months, and the curative effects were observed. Results The total effective rate were 89.4% in the treatment group, 66.3% in the control group A, and 70.2% in the control group B with significant difference(P 0.05). Conclusion The curative effect of compound azimtamide entieric-coated tablets combined with mosapride for slow transit constipation was more significant than at of compound azimtamide entieric-coated tablets and mosapride used alone. The treatment can significantly ease symptoms such as abdominal distension in slow transmissive constipation. It is worthy of clinical promotion and further research.